KU Leuven spin-off that develops vaccines
AstriVax has raised €33M across 2 funding rounds from 9 investors, most recently a Grant round in May 2023. Based in Leuven, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
